Pain during infiltration of local anesthesia is linked to a higher intensity of pain 24 hours after cesarean delivery and ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

A new study ranked 12 arthritis treatments to figure out what exactly is worth patient dollars when treating knee ...

AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis: San Diego Thursday, June 5, 2025, 18:00 Hrs [IST] AnaptysBio, Inc., a clinic ...

Genetically engineered skin grafts exhibited a long-term ability to heal large, chronic wounds in patients with recessive ...

Detailed price information for Anaptysbio Inc (ANAB-Q) from The Globe and Mail including charting and trades.

Rheumatoid arthritis (RA) can be mild, moderate, or severe, and symptoms vary from person to person. Learn more about the stages of RA, along with treatment options.

How one of the oldest components of the human immune system can trigger a mysterious and little-understood syndrome.

Sanofi presents positive results from DISCOVER phase 4 study of Dupixent in atopic dermatitis patients with skin of colour at 2025 RAD conference: Paris Tuesday, June 10, 2025, 16 ...

TARRYTOWN, N.Y. and PARIS, June 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent ® (dupilumab) ...